[ad_1] The General Directorate of Drugs, Supplies and Drugs (Digemid), Ministry of Health (Minsa), ordered the withdrawal of 33 products containing valsartan (active ingredient used for hypertension in response to alerts issued …
Read More »They retired from 33 products with valsartan for possible carcinogenic impurity | Trade | Peru
